Suboxone is prescribed to treat opioid use disorder in conjunction with other treatments. Patients, however, have experienced dental problems during or after taking the drug and they are filing lawsuits against Indivior, the manufacturer. Indivior has profited from the opioid crisis but by doing so it created medical, financial and emotional problems for Suboxone patients. To date, lawsuits have been filed by patients who took the Suboxone sublingual film version – rather than the original oral tablet– before Indivior included a warning in January 2022 of Suboxone potential tooth decay. That warning came 20 years after the drug was approved.